464 results
Page 10 of 24
8-K
ovh2mv kn2b0e
7 Mar 12
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome
12:00am
8-K
k2h2k6zzrakp
8 Feb 12
Entry into a Material Definitive Agreement
12:00am
8-K
4be4ur1b
2 Feb 12
Other Events
12:00am
424B5
49wbamnl51de
15 Dec 11
Prospectus supplement for primary offering
12:00am
8-K
lakg2 79y
14 Dec 11
Entry into a Material Definitive Agreement
12:00am
8-K
igk3aig7mmmgbaypxl9
3 Aug 11
Results of Operations and Financial Condition
12:00am
8-K
cg1wmut2wh57uq p6
29 Jul 11
Other Events
12:00am
8-K
8u55e0zz1nddxp4nz
9 Jun 11
Other Events
12:00am
8-K
jyjew6mpev 5e42
11 May 11
Results of Operations and Financial Condition
12:00am
8-K
626mu6lr0ejht51e37
22 Mar 11
Results of Operations and Financial Condition
12:00am
424B5
sp3jt pcx
17 Feb 11
Prospectus supplement for primary offering
12:00am
424B5
l7mpkbu4 kakq6j9
15 Feb 11
Prospectus supplement for primary offering
12:00am
8-K
2qlbb6ejz xj440akn
9 Feb 11
Other Events
12:00am
8-K
EX-99.1
tb2ctv
9 Feb 11
Other Events
12:00am